Small protein that interacts with a ribonucleotide reductase...

Chemistry: molecular biology and microbiology – Condition responsive control process

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S004000, C435S375000, C435S384000, C435S260000, C436S063000

Reexamination Certificate

active

07125658

ABSTRACT:
The present invention provides for an isolated Sml1 protein or a homologue thereof. The present invention also provides for a screening assay for identifying compounds that are capable of reducing the division rate of a cell by altering an interaction between a ribonucleotide reductase and a Sml1 protein in the cell, which comprises: (a) contacting the cell with a compound, (b) comparing the division rate of the cell in step (a) with the division rate of the cell in the absence of the compound so as to determine whether the compound alters the interaction between the ribonucleotide reductase and the Sml1 protein of the cell, thereby reducing the cell division rate of the cell.

REFERENCES:
patent: 4393041 (1983-07-01), Brown et al.
patent: 4889806 (1989-12-01), Olsen et al.
patent: 5767134 (1998-06-01), Li et al.
patent: 5834279 (1998-11-01), Rubin et al.
patent: 6030942 (2000-02-01), Cooperman et al.
patent: 0726 277 (1996-08-01), None
patent: WO 00/17225 (2000-03-01), None
Nasr et al (C R Acad Sci III, 1994, vol. 317, pp. 607-613), abstract.
Sanchez et al (Science, 1996, vol. 271, pp. 357-360).
Abstract of Theisinger et al, Human Genetics, 1992, vol. 89, pp. 681-682).
Zhao et al, Molecular Cell, 1998, vol. 2, pp. 329-340).
Cohen et al, Nature, 1986, vol. 321, pp. 441-443.
Dutia et al, Nature, 1986, vol. 321, pp. 439-441.
U.S. Appl. No. 09/159,858, filed Sep. 24, 1998, on behalf of Rodney Rothstein et al.
International Search Report issued on May 3, 2000 in connection with PCT International Application No. PCT/US99/22260, filed Sep. 24, 1999, International Publication No. WO 00/17225 A3, published Mar. 30, 2000, on behalf of The Trustees of Columbia University In The City Of New York.
Written Opinion issued Sep. 12, 2000 in connection with PCT International Application No. PCT/US99/22260, filed Sep. 24, 1999, International Publication No. WO 00/17225 A3, published Mar. 30, 2000, on behalf of The Trustees of Columbia University In The City Of New York.
International Preliminary Examination Report issued on Jan. 11, 2001 in connection with PCT International Application No. PCT/US99/22260, filed Sep. 24, 1999, International Publication No. WO 00/17225 A3, published Mar. 30, 2000, on behalf of The Trustees of Columbia University In The City Of New York.
Arap, W. et al. (1998) “Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model,”Science279: 377-380.
Allen, J.B. et al. (1994) “The SAD1/RAD53 protein kinase controls multiple checkpoints and DNA damage-induced transcription in yeast,”Genes Dev.8: 2401-2415.
Barlow, C. et al. (1996) “Atm-Deficient Mice: A Paradigm Of Ataxia Telangiectasia,”Cell86: 159-171.
Desany, B.A. et al. (1998) “Recovery from DNA replicational stress Is the essential function of the S-phase checkpoint pathway,”Genes Dev.12: 2956-70.
Elledge, S.J. (1996) “Cell cycle checkpoints: preventing an identity crisis,”Science274: 1664-1672.
Elson, A. et al. (1996) “Pleiotropic defects in ataxia-telangiectasia protein-deficient mice,”Proc. Natl. Acad. Sci. USA93: 13084-13089.
Fay, D.S. et al. (1997) “Mutations inSPK1/RAD53that specifically abolish checkpoint but not growth-related functions,”Curr. Genet.31: 97-105.
James, P. et al. (1996) “Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast,”Genetics144: 1425-1436.
Kato, R. et al. (1994) “An essential gene,ESR1, is required for mitotic cell growth, DNA repair and meiotic recombination inSaccharomyces cerevisiae,” Nucleic Acids Res.22: 3104-3112.
Koch, C. et al. (1993) “A role for the transcription factors Mbpl and Swi4 in progression from G1 to S phase,”Science261: 1551-1557.
Lecrenier, N. et al. (1995) “Overexpression of theRNR1gene rescuesSaccharomyces cerevisiaemutants in the mitochondrial DNA polymerase-encodingMIPIgene,”Mol. Gen. Genet.249: 1-7.
Liuzzi, M. et al. (1994) “A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activityin vivo,” Nature372: 695-698.
Reichard, P. (1988) “Interactions between deoxyribonucleotide and DNA synthesis,”Ann. Rev. Biochem.57: 349-374.
Sanchez, Y. et al. (1996) “Regulation ofRAD53by theATM-like kinasesMEC1andTEL1in yeast cell cycle checkpoint pathways,”Science271: 357-360.
Shewach, D.S. et al. (1996) “Gemcitabine and radiosensitization in human tumor cells,”Invest. New Drugs14: 257-263.
Shiloh, Y. (1997) “Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart,”Annu. Rev. Genet.31: 635-662.
Sun, Z. et al. (1996) “Spkl/Rad53 is regulated by Mecl-dependent protein phosphorylation in DNA replication and damage checkpoint pathways,”Genes Dev.10: 395-406.
Szekeres, T. et al. (1994) “Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase,”Cancer Chemther. Pharmacol.34: 63-66.
Vallen, E.A. et al. (1999) “Interaction between theMEC1-dependent DNA synthesis checkpoint and G1 cyclin function inSaccharomyces cerevisiae,” Genetics151: 459-71.
Wang, Y.A. et al. (1997) “Loss ofp21increases sensitivity to ionizing radiation and delays the onset of lymphoma inatm-deficient mice,”Proc. Natl. Acad. Sci. USA94: 14590-14595.
Westphal, C.H. et al. (1997) “Genetic interactions between atm andp53influence cellular proliferation and irradiation-induced cell cycle checkpoints,”Cancer Res.57: 1664-1667.
Xu, Y. et al. (1996) “Targeted disruption ofATMleads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma,”Genes Dev.10:2411-2422.
Xu, Y. et al. (1996) “Dual roles ofATMin the cellular response to radiation and in cell growth control,”Genes Dev.10: 2401-2410.
Zakian, V.A. (1995) “ATM-related genes: what do they tell us about functions of the human gene?,”Cell82: 685-687.
Zheng, P. et al. (1993) “SPK1is an essential S-phase-specific gene ofSaccharomyces cerevisiaethat encodes a nuclear serine/threonine/tyrosine kinase,”Mol. Cell. Biol.13: 5829-5842.
Barrell et al. (1997) (Genbank Accession No. Z46729, National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland).
Lewin (1988) “When Does Homology Mean Something Else?”Science237: 1570.
Miyakawa et al. (1991) Genbank Accession No. X54964 (National Center for Biotechnology Information, National Library of Medicine; Bethesda, Maryland).
Reeck et al. (1987) “Homology In Proteins and Nucleic Acids: A Terminology Muddle and a Way Out of It,”Cell50: 667.
Sambrook et al. (1987)Molecular Cloning, a Laboratory Manual(Cold Spring Harbor Press) : 16.3-16.4.
Devlin et al. (1997) Genbank Accession No. Q04964, Hypothetical 11.8 kD protein in OGG1-CNA2 intergenic region, Gene Sequence.
Ahn et al. (1993) “The Structural and Functional Diversity of Dystrophin,”Nature Genetics3: 283-291.
Cawthon et al. (1991) “cDNA Sequence and Genomic Structure of EVl2B, a Gene Lying Within An Intro of the Neurofibromatosis Type 1 Gene,”Genomics9: 446-460.
Harris et al. (1995) “Polycystic Kidney Disease 1: Identification and Analysis of the Primary Defect,”J. Am. Soc. Nephrology6: 1125-1133.
Liu et al. (1991)Mol. Gen. Genet.227: 52-59.
Reiger et al. (1976)Glossary of Genetics and Cytogenetics, Classical and Molecular, 4th Edition (Springer-Verlag, Berlin) pp. 17-18.
Saitoh et al. (1991)Biomed. Res.12: 215-218.
Bradford, M.M. (1976) “A Rapid and Sensitive Method For The Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding,”Anal. Biochem.72: 248-254.
Chance, B. and Herbert, D. (1950) “The Enzyme-substrate Compounds of Bacterial Catalase and Peroxides,”J. Biochem.46: 402-414.
Davis, R. et al. (1994) “Purification, Characterization and Localization of Subunit In

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Small protein that interacts with a ribonucleotide reductase... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Small protein that interacts with a ribonucleotide reductase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small protein that interacts with a ribonucleotide reductase... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3622289

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.